MedPath

Ladiratuzumab vedotin

Generic Name
Ladiratuzumab vedotin
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
1629760-29-7
Unique Ingredient Identifier
VM4G5D1A60
Background

Ladiratuzumab vedotin is under investigation in clinical trial NCT01969643 (A Safety Study of SGN-LIV1A in Breast Cancer Patients).

Associated Conditions
-
Associated Therapies
-
© Copyright 2025. All Rights Reserved by MedPath